Andera Partners and Life Sciences Partners (LSP) have led an $84m series-B funding round for UK-based biotech company Artios Pharma.
Acquisition gives Søgemedier a base in Sweden, along with its investment in Danish Søgemedier
Board of the UK insurance company has approved an offer of 280 pence apiece from the GP
Company will use the funding to target new markets, primarily in the automotive paint work segment
GP established a new vehicle, Alter Cap II, to purchase the fund’s portfolio and provide capital